AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10754734
Drug: Endoventricular plasty
RxNorm normalized name: cerliponase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoventricular plasty with patch (group A)
Trial: 10754734
Drug: Endoventricular plasty
RxNorm normalized name: cerliponase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoventricular plasty without patch (group B)
Trial: 7739102
Drug: Midazolam-famotidine suppository
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam-famotidine suppository (0.5 mg.kg‐1 midazolam and 2 mg.kg‐1 famotidine)
Trial: 7739102
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of hydroxyzine (1 mg.kg‐1)
Trial: 7739102
Drug: Midazolam-famotidine suppository
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam-famotidine suppository
Trial: 31838445
Drug: Nicotine e‐cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine e‐cigarette (8 mg/mL nicotine concentration)
Trial: 29532718
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin fluorouracil followed by conventional radiotherapy
Trial: 29532718
Drug: Conventional radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional radiotherapy with concurrent cisplatin
Trial: 18555546
Drug: Accelerated whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated whole brain irradiation (40 Gy in 20 fractions of 2 Gy twice daily)
Trial: 18555546
Drug: Conventional whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional whole brain irradiation (20 Gy in 5 daily fractions)
Trial: 14504153
Drug: 36 ml
RxNorm normalized name: ALCOHOL 177 mL in 236 mL TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 36 ml of mepivacaine 10 mg x ml(‐1)
Trial: 14504153
Drug: 28 ml
RxNorm normalized name: ethanol 0.28 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 28 ml of mepivacaine 10 mg x ml(‐1)
Trial: 14504153
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml of mepivacaine 10 mg x ml(‐1)
Trial: 10389555
Drug: 1% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% ropivacaine and hyaluronidase 75 units/ml
Trial: 10389555
Drug: 1:1 mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1:1 mixture of 2% lignocaine and 0.5% bupivacaine and hyaluronidase 75 units/ml
Trial: 1867082
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose treatment with trimethoprim
Trial: 1867082
Drug: 5-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day course treatment with trimethoprim
Trial: 23106658
Drug: Trichuris suis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trichuris suis ova (2500 ova, 3 weekly doses over 6 months)
Trial: 19715417
Drug: Acyclovir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (400 mg 3 times daily for 5 days)
Trial: 17559753
Drug: Tramadolor (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadolor (200 mg, test formulation)
Trial: 17559753
Drug: Ultram ER
RxNorm normalized name: Ultram ER
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ultram ER (200 mg, reference formulation)
Trial: 12038917
Drug: On-treatment analyses
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: On-treatment analyses
Trial: 9533973
Drug: Fluoxetine or
RxNorm normalized name: fluoxetine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine or Doxepin
Trial: 9533973
Drug: Nonresponse group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonresponse group (Fluoxetine or Doxepin)
Trial: 2796855
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with vincristine, doxorubicin and prednisone (VAP), consolidation therapy with 6‐thioguanine, cytosine arabinoside (TA) and cyclophosphamide/vincristine/cytosine arabinoside/prednisone (COAP), and maintenance therapy of alternating TA and COAP with or without VAP pulses.
Trial: 25993906
Drug: Local trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local trial - inhalation of a hypercapnic gas mixture (5% CO2 in air) for 5 minutes with open circulation to active calf muscle, followed by PECO.
Trial: 25993906
Drug: Systemic trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic trial - circulation through the muscle closed throughout exercise and PECO phases during hypercapnic gas inhalation.
Trial: 25993906
Drug: Hyperoxia trial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperoxia trial - inhalation of a hyperoxic hypercapnic gas mixture (95% O2 and 5% CO2) for 1 minute during PECO under systemic conditions.
Trial: 23881421
Drug: Grape seed
RxNorm normalized name: grape seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape seed extract (100 mg capsules three times daily)
Trial: 15028823
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of alendronate daily for 10 years
Trial: 9443925
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of alendronate daily
Trial: 15028823
Drug: Placebo after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo after discontinuation
Trial: 8129541
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg SL
Trial: 8129541
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg SL
Trial: 3628610
Drug: d-amphetamine 20
RxNorm normalized name: dextroamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 20 mg/70 kg
Trial: 31571403
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mirabegron 50 mg/d plus solifenacin 5 mg/d
Trial: 31571403
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mirabegron 50 mg/d plus propiverine 20 mg/d
Trial: 31571403
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mirabegron 50 mg/d plus imidafenacin 0.2 mg/d
Trial: 31571403
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mirabegron 50 mg/d plus tolterodine 4 mg/d
Trial: 31571403
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (including mirabegron 50 mg once daily during screening)
Trial: 26395781
Drug: Probiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplementation with general therapy
Trial: 26395781
Drug: General therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General therapy (antibiotics only)
Trial: 7769295
Drug: Vaccine adjuvanted
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine adjuvanted with alum
Trial: 7769295
Drug: Vaccine adjuvanted
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine adjuvanted with alum plus 3-deacylated monophosphoryl lipid A (MPL)
Trial: 7769295
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (alum and alum-MPL)
Trial: 2284521
Drug: Metronidazole pessaries
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole pessaries (500 mg, once daily for 7 days)
Trial: 94616
Drug: Indapamide 2.5
RxNorm normalized name: indapamide 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 2.5 mg per day
Trial: 3534848
Drug: Moduretic (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moduretic (50 mg hydrochlorothiazide and 5 mg amiloride)
Trial: 6195479
Drug: NTG after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTG after 1 g of oral aspirin pretreatment
Trial: 6195479
Drug: NTG after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTG after 8 days of aspirin, 500 mg every 48 h
Trial: 6195479
Drug: NTG without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTG without aspirin pretreatment
Trial: 31138568
Drug: ASN100 (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN100 (combination of ASN‐1 and ASN‐2) at 3,600 or 8,000 mg
Trial: 31138568
Drug: ASN100 (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN100 (combination of ASN‐1 and ASN‐2)
Trial: 31138568
Drug: ASN‐1 or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN‐1 or ASN‐2 at 200, 600, 1,800, or 4,000 mg
Trial: 31138568
Drug: Open-label ASN100
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label ASN100 at 3,600 or 8,000 mg
Trial: 29563100
Drug: Tai chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai chi (12 or 24 weeks, once or twice weekly)
Trial: 29563100
Drug: Tai chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai chi (24 weeks, twice weekly)
Trial: 29563100
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise (24 weeks, twice weekly)
Trial: 22377744
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline at daily doses of 200, 300, 400, 600, and 800 mg for periods of 2‐10 months
Trial: 11861971
Drug: Chlorpyrifos (CPF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpyrifos (CPF) administered orally at doses of 0.5-100 mg/kg in rats and 0.5-2 mg/kg in humans.
Trial: 1977464
Drug: Terfenadine 60
RxNorm normalized name: terfenadine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 60 mg bd
Trial: 1977464
Drug: Terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 120 mg bd
Trial: 40798
Drug: metoprolol 10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 10, 40 or 50 mg
Trial: 40798
Drug: alprenolol 200
RxNorm normalized name: alprenolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alprenolol 200 mg
Trial: 17207073
Drug: Topical capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical capsaicin cream (0.075%) applied unilaterally to the mental area, four times daily for 2 weeks
Trial: 17207073
Drug: Topical capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical capsaicin cream (0.075%)
Trial: 15347608
Drug: Hyperbaric ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric ropivacaine 10 mg/ml (1.5 ml) with glucose 300 mg/ml (0.5 ml)
Trial: 15347608
Drug: Plain ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain ropivacaine 7.5 mg/ml (2 ml)
Trial: 3548803
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (AD and estimated weight reported)
Trial: 31402538
Drug: Obeticholic acid
RxNorm normalized name: Obeticholic acid
DrugBank: Obeticholic acid (DB05990)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Obeticholic acid (OCA) 5 mg, 10 mg, or 25 mg once daily
Trial: 27658659
Drug: Antioxidant ice
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant ice cream (100 g containing dark cocoa powder, hazelnut, and green tea extracts)
Trial: 27658659
Drug: Milk chocolate
RxNorm normalized name: Meritene Milk Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk chocolate ice cream (control ice cream)
Trial: 23597082
Drug: Motivational interviewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational interviewing and problem solving treatment (n=314)
Trial: 21568075
Drug: Paracetamol (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1000 mg t.i.d.)
Trial: 21568075
Drug: Amlodipine +/‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine +/‐ ibuprofen
Trial: 21568075
Drug: Lisinopril/hydrochlorothiazide +/‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril/hydrochlorothiazide +/‐ piroxicam
Trial: 11071672
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiotherapy (cisplatin 60 mg/m² on day 1, etoposide 120 mg/m² on days 1-3, concurrent with radiotherapy 50.4 Gy in 28 fractions)
Trial: 8851570
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg twice daily with food
Trial: 8851570
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg once daily with food
Trial: 8851570
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg twice daily fasting
Trial: 8851570
Drug: 1,500 mg
RxNorm normalized name: garlic 1,500 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,500 mg single dose
Trial: 8851570
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg single dose
Trial: 8851570
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg twice daily with high-fat meal
Trial: 1315665
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy plus plasmapheresis (plasma exchange)
Trial: 1315665
Drug: Standard drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drug therapy alone
Trial: 29903344
Drug: Dual-antiplatelet therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-antiplatelet therapy (DAPT) - aspirin 325 mg and clopidogrel 75 mg
Trial: 29903344
Drug: Lower intensity
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower intensity warfarin plus aspirin (INR 1.5 to 2.0)
Trial: 29903344
Drug: Standard warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard warfarin plus aspirin (INR 2.0 to 3.0)
Trial: 8526179
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with specific hyposensitization (Abelló Lab., Spain) for 12 months
Trial: 1483486
Drug: S-1452 50
RxNorm normalized name: HYMETELLOSE (50 MPA.S)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1452 50 mg
Trial: 6529162
Drug: Alizapride (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alizapride (50 mg)
Trial: 21865319
Drug: Silymarin (280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin (280 or 560 mg) every 8 hours for 7 days
Trial: 11728684
Drug: Pelvic radiotherapy
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic radiotherapy (RT) at a dosage of 46 Gy
Trial: 9106379
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg diphenhydramine
Trial: 28671879
Drug: Protective ventilation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective ventilation (Vt 7 mL/kg-PEEP 5 mm Hg)
Trial: 28671879
Drug: Traditional ventilation
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional ventilation (Vt 9 mL/kg-PEEP 0 mm Hg)
Trial: 23903901
Drug: Intrathecal normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal normal saline 5 ml before intrathecal injection of 2.5 ml (12.5 mg) hyperbaric bupivacaine 0.5%
Trial: 23903901
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 2.5 ml (12.5 mg) hyperbaric bupivacaine 0.5%
Trial: 22652586
Drug: High OVA
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High OVA IgA antibodies in colostrum
Trial: 20736446
Drug: Hypothermia (cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermia (cold saline infusion and endovascular cooling)
Trial: 15845775
Drug: Anti-G suit
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-G suit inflated to 85 mmHg at 1 G
Trial: 15845775
Drug: Anti-G suit
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-G suit inflated to 85 mmHg at 2 G
Trial: 10047926
Drug: Sublingual apomorphine
RxNorm normalized name: apomorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual apomorphine hydrochloride (APO)
Trial: 10047926
Drug: Optimal doses
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal doses of carbidopa/levodopa
Trial: 2251632
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) oral tablets used intravaginally
Trial: 26616798
Drug: APC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APC with medicine group (Esomeprazole 40 mg/d after APC treatment for 8 weeks)
Trial: 26616798
Drug: APC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APC with surgery group (Laparoscopic hiatal hernia repair and Nissen fundoplication after APC treatment)
Trial: 19820283
Drug: P-OM3 4
RxNorm normalized name: P
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P-OM3 4 g/day + fenofibrate 130 mg/day
Trial: 19820283
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 g/day corn oil) + fenofibrate 130 mg/day
Trial: 17955091
Drug: Antiepileptic drugs
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiepileptic drugs (AEDs) such as gabapentin and pregabalin
Trial: 11298069
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of racemic halofantrine once daily in the fasted state for 42 days
Trial: 2647907
Drug: Low-dose bromocriptine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bromocriptine (less than 30 mg/day)
Trial: 2647907
Drug: Low-dose levodopa-carbidopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose levodopa-carbidopa (less than 600/150 mg/day)
Trial: 20568433
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Sulfasalazine
Trial: 16891998
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral therapy (CBT) and pill placebo
Trial: 16891998
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of moclobemide and group cognitive-behavioral therapy
Trial: 16891998
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (pill placebo)
Trial: 2049967
Drug: Ofloxacin (OFX)
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin (OFX) treatment
Trial: 2049967
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with Ofloxacin (OFX) and a single dose of aminoglycoside (isepamicin)
Trial: 6128447
Drug: Rectal PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal PGE2
Trial: 23438803
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 2% articaine (Group A)
Trial: 23438803
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL 2% articaine + 10 mL 0.75% ropivacaine (Group AR)
Trial: 23438803
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 0.75% ropivacaine (Group R)
Trial: 21543543
Drug: Early nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early nutrition program with varying diets during the neonatal period (no phosphate supplements provided)
Trial: 16959618
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 microg once daily from a dry powder inhaler (HandiHaler)